Ophthalmic Product Development Insights
A look at ocular/nasal interactions and how they can affect our pharmaceutical therapies.
A look at the latest research from multiple corners of ophthalmology, from gene therapy to dry eye.
DEXTENZA successfully met primary endpoint for treatment of ocular itching associated with allergic conjunctivitis
Cutting-edge progress also continues in retina, cornea, dry eye, gene-based science
A rundown of the most interesting research in a variety of subspecialties presented at this year’s ARVO meeting.
The placid ocular surface is actually teeming with life that might hold the secret to treating ophthalmic disease.
Allergic conjunctivitis is a common and potentially debilitating condition affecting the conjunctiva, eyelids and cornea, and it is often associated with nonocular symptoms and signs of rhinitis or sinusitis.
Customer Success Stories: Celebrating Your Big Wins in 2014-2015
Clinical trial for the treatment of allergic rhinitis for 3E Therapeutics Corporation